# PTGES2

## Overview
PTGES2, or prostaglandin E synthase 2, is a gene that encodes an enzyme involved in the biosynthesis of prostaglandin E2 (PGE2), a lipid compound that plays a critical role in various physiological processes. The enzyme, categorized as a microsomal prostaglandin E synthase, is constitutively expressed in multiple tissues, including the brain, heart, and liver, and is involved in maintaining tissue homeostasis (Tanikawa2002Identification; Murakami2003Cellular). Unlike its inducible counterpart PTGES1, PTGES2 is not significantly upregulated during inflammation, indicating its role in basal PGE2 production (Murakami2003Cellular; Lindner2007Prostaglandin). The enzyme is initially synthesized as a Golgi membrane-associated protein and undergoes proteolytic cleavage to function in the cytosol, particularly in the perinuclear region (Murakami2003Cellular). PTGES2 is involved in various physiological processes, including smooth muscle function and body temperature regulation, and has been implicated in several diseases, making it a potential target for therapeutic interventions (Tanikawa2002Identification; Zhong2023Targeting).

## Function
PTGES2, or prostaglandin E synthase 2, is an enzyme involved in the biosynthesis of prostaglandin E2 (PGE2) from prostaglandin H2 (PGH2). This enzyme is constitutively expressed in various tissues, including the brain, heart, skeletal muscle, kidney, and liver, indicating its role in maintaining tissue homeostasis (Tanikawa2002Identification; Murakami2003Cellular). PTGES2 is capable of coupling with both cyclooxygenase-1 (COX-1) and cyclooxygenase-2 (COX-2) enzymes, facilitating PGE2 production in both immediate and delayed phases (Murakami2003Cellular). Unlike PTGES1, which is inducible by inflammatory stimuli, PTGES2 is not significantly upregulated during inflammation, suggesting its involvement in basal PGE2 production (Murakami2003Cellular; Lindner2007Prostaglandin).

In cellular biology, PTGES2 is initially synthesized as a Golgi membrane-associated protein and undergoes proteolytic cleavage, resulting in a mature form that is distributed in the cytosol, particularly in the perinuclear region (Murakami2003Cellular). This enzyme plays a role in various physiological processes, including smooth muscle function, sodium excretion, and body temperature regulation (Tanikawa2002Identification). Its activity is essential for the conversion of arachidonic acid to PGE2, a process crucial for maintaining cellular and tissue functions (Murakami2003Cellular).

## Clinical Significance
The PTGES2 gene has been implicated in several diseases due to its role in prostaglandin E2 synthesis. Mutations and polymorphisms in PTGES2, such as the Arg298His polymorphism, have been associated with a reduced risk of type 2 diabetes. Studies in German populations have shown that carriers of the His298 allele have a significantly lower risk of developing type 2 diabetes, with pooled odds ratios indicating a protective effect (Nitz2007Association).

In the context of cancer, PTGES2 has been identified as a potential biomarker and therapeutic target for basal cell carcinoma (BCC). Research indicates that PTGES2 is associated with a protective effect against BCC, as evidenced by its significant colocalization with BCC risk factors in genetic studies (Han2024PTGES2). However, PTGES2 does not show a similar association with other skin cancer types like melanoma (Han2024PTGES2).

In pancreatic ductal adenocarcinoma (PDAC), PTGES2 expression is linked to a better prognosis for overall survival, contrasting with the oncogenic role of other PTGES isoforms in this cancer type (Murthy2023PTGES). These findings suggest that PTGES2 may have diverse roles in different disease contexts.

## Interactions
PTGES2, also known as microsomal prostaglandin E synthase-2, is involved in several protein interactions that influence its function in physiological processes. PTGES2 forms a complex with glutathione (GSH) and heme, which is crucial for its enzymatic activity. This complex catalyzes the conversion of prostaglandin H2 (PGH2) to malondialdehyde (MDA) and other compounds, although not to prostaglandin E2 (PGE2) in tissues rich in heme (Zhong2023Targeting). The interaction with heme is particularly significant as it regulates the p53/SLC7A11/GPX4 axis, which is involved in ferroptosis, a form of regulated cell death (Zhong2023Targeting).

PTGES2 also interacts with the p53 protein, influencing its expression and function. This interaction is mediated by heme, which can bind to p53, affecting its role in cellular stress responses and ferroptosis (Zhong2023Targeting). These interactions highlight PTGES2's role in cellular processes related to oxidative stress and cell death, making it a potential target for therapeutic interventions in conditions like acute kidney injury (AKI) (Zhong2023Targeting).


## References


[1. (Nitz2007Association) Inke Nitz, Eva Fisher, Harald Grallert, Yun Li, Christian Gieger, Diana Rubin, Heiner Boeing, Joachim Spranger, Inka Lindner, Stefan Schreiber, Wolfgang Rathmann, Henning Gohlke, Angela Döring, H.-Erich Wichmann, Jürgen Schrezenmeir, Frank Döring, and Thomas Illig. Association of prostaglandin e synthase 2 (ptges2) arg298his polymorphism with type 2 diabetes in two german study populations. The Journal of Clinical Endocrinology &amp; Metabolism, 92(8):3183–3188, August 2007. URL: http://dx.doi.org/10.1210/jc.2006-2550, doi:10.1210/jc.2006-2550. This article has 23 citations.](https://doi.org/10.1210/jc.2006-2550)

[2. (Tanikawa2002Identification) Naomi Tanikawa, Yoshihiro Ohmiya, Hiroaki Ohkubo, Katsuyuki Hashimoto, Kenji Kangawa, Masami Kojima, Seiji Ito, and Kikuko Watanabe. Identification and characterization of a novel type of membrane-associated prostaglandin e synthase. Biochemical and Biophysical Research Communications, 291(4):884–889, March 2002. URL: http://dx.doi.org/10.1006/bbrc.2002.6531, doi:10.1006/bbrc.2002.6531. This article has 246 citations and is from a peer-reviewed journal.](https://doi.org/10.1006/bbrc.2002.6531)

[3. (Murthy2023PTGES) Divya Murthy and Kuldeep S. Attri. Ptges expression is associated with metabolic and immune reprogramming in pancreatic ductal adenocarcinoma. International Journal of Molecular Sciences, 24(8):7304, April 2023. URL: http://dx.doi.org/10.3390/ijms24087304, doi:10.3390/ijms24087304. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms24087304)

[4. (Lindner2007Prostaglandin) Inka Lindner, Ulf Helwig, Diana Rubin, Alexandra Fischer, Berit Marten, Stefan Schreiber, Frank Döring, and Jürgen Schrezenmeir. Prostaglandin e synthase 2 (ptges2) arg298his polymorphism and parameters of the metabolic syndrome. Molecular Nutrition &amp; Food Research, 51(12):1447–1451, December 2007. URL: http://dx.doi.org/10.1002/mnfr.200700144, doi:10.1002/mnfr.200700144. This article has 12 citations.](https://doi.org/10.1002/mnfr.200700144)

[5. (Han2024PTGES2) Qiu-Ju Han, Yi-Pan Zhu, Jing Sun, Xin-Yu Ding, Xiuyu Wang, and Qiang-Zhe Zhang. Ptges2 and rnaset2 identified as novel potential biomarkers and therapeutic targets for basal cell carcinoma: insights from proteome-wide mendelian randomization, colocalization, and mr-phewas analyses. Frontiers in Pharmacology, July 2024. URL: http://dx.doi.org/10.3389/fphar.2024.1418560, doi:10.3389/fphar.2024.1418560. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fphar.2024.1418560)

[6. (Murakami2003Cellular) Makoto Murakami, Karin Nakashima, Daisuke Kamei, Seiko Masuda, Yukio Ishikawa, Toshiharu Ishii, Yoshihiro Ohmiya, Kikuko Watanabe, and Ichiro Kudo. Cellular prostaglandin e2 production by membrane-bound prostaglandin e synthase-2 via both cyclooxygenases-1 and -2. Journal of Biological Chemistry, 278(39):37937–37947, September 2003. URL: http://dx.doi.org/10.1074/jbc.m305108200, doi:10.1074/jbc.m305108200. This article has 276 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m305108200)

[7. (Zhong2023Targeting) Dandan Zhong, Lingling Quan, Chang Hao, Jingshuo Chen, Ranran Qiao, Tengfei Lin, Changjiang Ying, Dong Sun, Zhanjun Jia, and Ying Sun. Targeting mpges-2 to protect against acute kidney injury via inhibition of ferroptosis dependent on p53. Cell Death &amp; Disease, October 2023. URL: http://dx.doi.org/10.1038/s41419-023-06236-7, doi:10.1038/s41419-023-06236-7. This article has 7 citations.](https://doi.org/10.1038/s41419-023-06236-7)